GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Precipio Inc (FRA:TGK) » Definitions » Cyclically Adjusted Revenue per Share

Precipio (FRA:TGK) Cyclically Adjusted Revenue per Share : €0.00 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Precipio Cyclically Adjusted Revenue per Share?

Note: As Cyclically Adjusted Revenue per Share is a main component used to calculate Cyclically Adjusted PS Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Precipio's adjusted revenue per share for the three months ended in Mar. 2024 was €2.287. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.00 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Precipio's average Cyclically Adjusted Revenue Growth Rate was -87.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -56.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -43.60% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -27.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Precipio was -13.30% per year. The lowest was -56.60% per year. And the median was -17.10% per year.

As of today (2024-06-09), Precipio's current stock price is €5.32. Precipio's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €0.00. Precipio's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Precipio was 1.06. The lowest was 0.01. And the median was 0.16.


Precipio Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Precipio's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precipio Cyclically Adjusted Revenue per Share Chart

Precipio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18,052.70 12,255.30 7,350.93 4,426.00 -

Precipio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,384.77 2,668.49 2,000.22 - -

Competitive Comparison of Precipio's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, Precipio's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Precipio's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Precipio's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Precipio's Cyclically Adjusted PS Ratio falls into.



Precipio Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Precipio's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.287/131.7762*131.7762
=2.287

Current CPI (Mar. 2024) = 131.7762.

Precipio Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 4,978.000 100.560 6,523.321
201409 3,154.000 100.428 4,138.517
201412 -8,398.000 99.070 -11,170.484
201503 693.000 99.621 916.682
201506 394.000 100.684 515.672
201509 147.000 100.392 192.956
201512 187.000 99.792 246.934
201603 106.000 100.470 139.029
201606 449.000 101.688 581.853
201609 325.000 101.861 420.448
201612 300.000 101.863 388.099
201703 232.000 102.862 297.214
201706 115.500 103.349 147.269
201709 9.080 104.136 11.490
201712 23.500 104.011 29.773
201803 13.738 105.290 17.194
201806 10.130 106.317 12.556
201809 7.234 106.507 8.950
201812 6.081 105.998 7.560
201903 3.669 107.251 4.508
201906 2.947 108.070 3.593
201909 2.304 108.329 2.803
201912 1.660 108.420 2.018
202003 2.625 108.902 3.176
202006 2.046 108.767 2.479
202009 1.726 109.815 2.071
202012 1.816 109.897 2.178
202103 1.716 111.754 2.023
202106 1.850 114.631 2.127
202109 1.682 115.734 1.915
202112 1.897 117.630 2.125
202203 1.958 121.301 2.127
202206 1.967 125.017 2.073
202209 1.966 125.227 2.069
202212 1.978 125.222 2.082
202303 2.266 127.348 2.345
202306 2.677 128.729 2.740
202309 3.034 129.860 3.079
202312 2.876 129.419 2.928
202403 2.287 131.776 2.287

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Precipio  (FRA:TGK) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Precipio was 1.06. The lowest was 0.01. And the median was 0.16.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Precipio Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Precipio's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Precipio (FRA:TGK) Business Description

Industry
Traded in Other Exchanges
Address
4 Science Park, New Haven, CT, USA, 06511
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings.

Precipio (FRA:TGK) Headlines

No Headlines